A compound of formula I ##STR1## or a pharmaceutically acceptable salt thereof in which R.sub.1 and R.sub.2 are independently H or methyl (for example N,N-dimethyl-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl amine hydrochloride optionally in the form of its monohydrate) is used for treating cardiovascular disease, such as dyslipidaemia or carotid intimal medial thickening.

 
Web www.patentalert.com

< Polymorphic form of a tachykinin receptor antagonist

< Use of CRF antagonists to treat circadian rhythm disorders

> Trisubstituted-oxazole derivatives as serotonin ligands

> Hydroxide-releasing agents as skin permeation enhancers

~ 00041